Dr. James M. Scanlon, MD

Dr. Scanlon practices at Cardiothoracic & Vascular Surgical Associates PA in Jacksonville, Florida.

Dr. Scanlon's NPI, 1265528319, was assigned on October 5, 2006. Dr. Scanlon graduated from George Washington University School of Medicine and Health Sciences in 2000. Dr. Scanlon holds Florida license ME105132.

Dr. Scanlon's primary practice is Cardiothoracic & Vascular Surgical Associates PA, at 1824 King St, Jacksonville, FL 32204 in Duval County. The practice phone is (904) 384-3343.

Dr. Scanlon's primary practice is Cardiothoracic & Vascular Surgical Associates PA in Jacksonville, Florida. Dr. Scanlon is also affiliated with Baptist Medical Center Jacksonville. The medical group on file is Cardiothoracic & Vascular Surgical Associates. Dmand AI also links Dr. Scanlon to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Scanlon practices, 6 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Scanlon's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Scanlon is board certified in registered physician in non-invasive vascular lab interpretation (rpvi) by the AAPC. Dmand AI has Dr. Scanlon's licenses on file in 4 states: Florida, District of Columbia, Maryland and Virginia.

Dmand AI lists amputation, aortic atherosclerois, arterial blot clot /embolism, carotid revascularization, chronic skin ulcer, deep vein thrombosis (DVT), heart device and aorta surgery and leg revascularization among the conditions Dr. Scanlon treats.

CMS data shows 1,807 Medicare services from Dr. Scanlon across 19 procedure codes in 2024, for 677 Medicare patients. Medicare paid $174,066 for them.

CMS counts 677 Medicare patients who saw Dr. Scanlon in 2024. The largest group is 75 to 84, with 386 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Scanlon's median patient age at 74, with 38% women.

In 2024, Dr. Scanlon wrote 364 Medicare Part D claims for 101 patients. 75% of them were for generic drugs. CMS names the drug for 309 of them, across 5 drugs with 11 or more claims each, at $56,906 in total drug cost. In 2023, CMS named 351 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Scanlon for performance year 2024, reported individually. Dr. Scanlon accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Scanlon, published from 2009 to 2022. Dr. Scanlon's most frequent co-authors are Reza Askari, MD, Robert J. Cubeddu, MD and William E. Hauda, MD.

CMS Open Payments shows 282 general payments to Dr. Scanlon from 30 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Medtronic Vascular, Inc. paid the most, $1,424.

Dmand AI lists 2 awards for Dr. Scanlon, most recently ACS Fellow in 2011.

Dr. Scanlon graduated from George Washington University School of Medicine and Health Sciences in 2000. Dr. Scanlon is a member of ACS and SVS.

Dr. Scanlon is in network with 10 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.